author-photo

Juhui James Jiao

Janssen Pharmaceutica

7

Papers

130

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Phase Ib study of apalutamide (APA) with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Update on safety and efficacy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants

2015 Pharmacology Research & Perspectives
Show All
- Source
- Cite
- Save
Citations (61)
Abstract B20: Pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment: Results from an open-label, multicenter study.

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1b study of ARN-509 with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer

2013 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (27)